Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney, pancreas, and brain - PubMed (original) (raw)
Review
Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney, pancreas, and brain
Aleksandra Fucic et al. Environ Health. 2012.
Abstract
The role of steroids in carcinogenesis has become a major concern in environmental protection, biomonitoring, and clinical research. Although historically oestrogen has been related to development of reproductive system, research over the last decade has confirmed its crucial role in the development and homeostasis of other organ systems. As a number of anthropogenic agents are xenoestrogens, environmental health research has focused on oestrogen receptor level disturbances and of aromatase polymorphisms. Oestrogen and xenoestrogens mediate critical points in carcinogenesis by binding to oestrogen receptors, whose distribution is age-, gender-, and tissue-specific. This review brings data about cancer types whose eatiology may be found in environmental exposure to xenoestrogens. Cancer types that have been well documented in literature to be related with environmental exposure include the reproductive system, breast, lung, kidney, pancreas, and brain. The results of our data mining show (a) a significant correlation between exposure to xenoestrogens and increased, gender-related, cancer risk and (b) a need to re-evaluate agents so far defined as endocrine disruptors, as they are also key molecules in carcinogenesis. This revision may be used to further research of cancer aetiology and to improvement of related legislation. Investigation of cancers caused by xenoestrogens may elucidate yet unknown mechanisms also valuable for oncology and the development of new therapies.
Figures
Figure 1
Schematic presentation of lung cancer development
Similar articles
- Endocrine disruption of oestrogen action and female reproductive tract cancers.
Gibson DA, Saunders PT. Gibson DA, et al. Endocr Relat Cancer. 2014 Mar 12;21(2):T13-31. doi: 10.1530/ERC-13-0342. Print 2014 Apr. Endocr Relat Cancer. 2014. PMID: 24163391 Review. - Molecular pathways: environmental estrogens activate nongenomic signaling to developmentally reprogram the epigenome.
Wong RL, Walker CL. Wong RL, et al. Clin Cancer Res. 2013 Jul 15;19(14):3732-7. doi: 10.1158/1078-0432.CCR-13-0021. Epub 2013 Apr 2. Clin Cancer Res. 2013. PMID: 23549878 Free PMC article. - Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha.
Recchia AG, Vivacqua A, Gabriele S, Carpino A, Fasanella G, Rago V, Bonofiglio D, Maggiolini M. Recchia AG, et al. Food Addit Contam. 2004 Feb;21(2):134-44. doi: 10.1080/02652030310001641177. Food Addit Contam. 2004. PMID: 14754635 - Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps.
Mattison DR, Karyakina N, Goodman M, LaKind JS. Mattison DR, et al. Crit Rev Toxicol. 2014 Sep;44(8):696-724. doi: 10.3109/10408444.2014.930813. Epub 2014 Aug 6. Crit Rev Toxicol. 2014. PMID: 25099693 Review. - Xenoestrogens impact brain estrogen receptor signaling during the female lifespan: A precursor to neurological disease?
Reddy V, McCarthy M, Raval AP. Reddy V, et al. Neurobiol Dis. 2022 Feb;163:105596. doi: 10.1016/j.nbd.2021.105596. Epub 2021 Dec 20. Neurobiol Dis. 2022. PMID: 34942334 Review.
Cited by
- Occurrence, efficiency of treatment processes, source apportionment and human health risk assessment of pharmaceuticals and xenoestrogen compounds in tap water from some Ghanaian communities.
Adjei JK, Acquah H, Essumang DK. Adjei JK, et al. Heliyon. 2024 May 23;10(11):e31815. doi: 10.1016/j.heliyon.2024.e31815. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38845891 Free PMC article. - Lifestyle Factors and Cancer: A Narrative Review.
Sharman R, Harris Z, Ernst B, Mussallem D, Larsen A, Gowin K. Sharman R, et al. Mayo Clin Proc Innov Qual Outcomes. 2024 Mar 4;8(2):166-183. doi: 10.1016/j.mayocpiqo.2024.01.004. eCollection 2024 Apr. Mayo Clin Proc Innov Qual Outcomes. 2024. PMID: 38468817 Free PMC article. - High-Grade Serous Ovarian Cancer-A Risk Factor Puzzle and Screening Fugitive.
Wilczyński J, Paradowska E, Wilczyński M. Wilczyński J, et al. Biomedicines. 2024 Jan 19;12(1):229. doi: 10.3390/biomedicines12010229. Biomedicines. 2024. PMID: 38275400 Free PMC article. Review. - Herbal Treatment of Female Urogenital Atrophy: A Retrospective Cohort Analysis.
Ritzmann D. Ritzmann D. Complement Med Res. 2024;31(2):124-132. doi: 10.1159/000536193. Epub 2024 Jan 11. Complement Med Res. 2024. PMID: 38211573 Free PMC article. - Endocrine Effect of Some Mycotoxins on Humans: A Clinical Review of the Ways to Mitigate the Action of Mycotoxins.
Kościelecka K, Kuć A, Kubik-Machura D, Męcik-Kronenberg T, Włodarek J, Radko L. Kościelecka K, et al. Toxins (Basel). 2023 Aug 23;15(9):515. doi: 10.3390/toxins15090515. Toxins (Basel). 2023. PMID: 37755941 Free PMC article. Review.
References
- Pritchard-Jones K, Kaatsch P, Steliarova-Foucher E, Stiller CA, Coebergh JWW. Cancer in children and adolescence in Europe: developments over 20 years and future challenges. European J Cancer. 2006;42:2183–2190. - PubMed
- Ferlay J, Autier P, Boniol M, Heaune M, Colombet M, Boyle P. Estimates of the incidence and mortality in Europe in 2. Annals of Oncology. 2007;18:581–592. - PubMed
- Moss RL, Gu O, Wong M. Estrogen: nontranscriptional signaling pathway. Recent Prog Horm Res. 1997;52:33–68. - PubMed
- Wooley CS. Acute effects of estrogen on neuronal physiology. Ann RevPharmacol Toxicol. 2007;47:657–80. - PubMed
- Fucic A, Miškov S, Zeljezic D, Bogdanovic N, Katic J, Gjergja R, Karelson E, Gamulin M. Is the role of estrogens and estrogen receptors in epilepsy still underestimated? Medical Hypotheses. 2009;73:703–705. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials